# Cross-domain antimicrobial resistance in poultry farming: A One Health assessment of antimicrobial use and multidrug resistance in Kiambu County, Kenya

**Authors:** Ann Kangai Munene, Peter Muiruri Mwangi, Lilly Caroline Bebora, Christine Minoo Mbindyo, John Muthini Maingi

PMC · DOI: 10.14202/vetworld.2026.1-14 · 2025-01-06

## TL;DR

This study examines antimicrobial use and resistance in poultry farming in Kenya, finding high resistance in bacteria from humans, chickens, and the environment.

## Contribution

The study provides a One Health assessment of antimicrobial use and resistance in poultry farming in Kenya, linking human, animal, and environmental domains.

## Key findings

- High resistance to ampicillin, tetracycline, and trimethoprim–sulfamethoxazole was observed in E. coli isolates.
- Enterococcus isolates showed high erythromycin resistance and moderate ciprofloxacin resistance.
- Antimicrobial use patterns were associated with resistance outcomes, highlighting the need for better stewardship.

## Abstract

Antimicrobial resistance (AMR) has emerged as a major One Health threat driven by inappropriate antimicrobial use (AMU) in humans, animals, and the environment. Poultry production is recognized as a key reservoir of antimicrobial-resistant bacteria, yet few studies in Kenya examine AMU and AMR across interconnected human–animal–environment domains. This study assessed AMU patterns among poultry farmers in Kiambu County and characterized phenotypic resistance in Escherichia coli and Enterococcus spp. isolated from humans, chickens, and chicken environments.

A cross-sectional study was conducted from June to September 2024, involving 102 poultry farms. Farm demographics and AMU data were collected using a semi-structured questionnaire. Archived E. coli (n = 92) and Enterococcus spp. (n = 101) isolates from chicken handlers’ hands, chickens, and environmental samples were subjected to antimicrobial susceptibility testing using the Kirby–Bauer method per Clinical and Laboratory Standards Institute (CLSI) 2024 guidelines. Descriptive and inferential statistics, including logistic regression with false discovery rate correction, were used to assess associations between AMU and phenotypic resistance.

Macrolides (69%), tetracyclines (48%), and sulfonamides (21%) were the most commonly used antimicrobials; 7% of farms reported colistin use. Among E. coli isolates, resistance was highest to ampicillin (77%), tetracycline (72%), and trimethoprim–sulfamethoxazole (49%), with 35% exhibiting multidrug resistance (MDR). No carbapenem resistance was detected. Enterococcus isolates showed high erythromycin resistance (61%) and moderate ciprofloxacin resistance (26%), with 6.9% exhibiting MDR; no vancomycin-resistant enterococci (VRE) were observed. Penicillin use strongly predicted ampicillin resistance in both organisms, whereas sulfonamide use was associated with reduced trimethoprim–sulfamethoxazole resistance. Macrolide use did not correlate with erythromycin resistance.

High AMU in poultry farming, particularly of macrolides, tetracyclines, and sulfonamides, has created significant selection pressure, contributing to MDR emergence across One Health interfaces. Detection of resistance in humans, poultry, and shared environments underscores the bidirectional risk of AMR transmission. Strengthened antimicrobial stewardship, regulation of critically important antimicrobials, and enhanced farm hygiene are essential to mitigate AMR. These findings directly support Kenya’s Vision 2030 and SDGs targeting health, responsible production, and environmental protection.

## Linked entities

- **Chemicals:** colistin (PubChem CID 5311054), ampicillin (PubChem CID 6249), trimethoprim–sulfamethoxazole (PubChem CID 358641), erythromycin (PubChem CID 12560), ciprofloxacin (PubChem CID 2764), vancomycin (PubChem CID 14969), penicillin (PubChem CID 2349)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Diseases:** VRE (MESH:D060467), MDR (MESH:D018088)
- **Chemicals:** erythromycin (MESH:D004917), tetracyclines (MESH:D013754), carbapenem (MESH:D015780), vancomycin (MESH:D014640), ciprofloxacin (MESH:D002939), sulfonamide (MESH:D013449), trimethoprim-sulfamethoxazole (MESH:D015662), ampicillin (MESH:D000667), Macrolide (MESH:D018942), tetracycline (MESH:D013752), Penicillin (MESH:D010406)
- **Species:** Enterococcus (genus) [taxon 1350], Escherichia coli (E. coli, species) [taxon 562], Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975725/full.md

---
Source: https://tomesphere.com/paper/PMC12975725